List of insiders holdings for Eloxx Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Klaver Paul Edward 10% Owner | 2012-04-24 14:07:29 | 11,791,670 0 | 11,791,670 | Form 13G |
| Pontifax Management 4 G.P. (2015) Ltd. Pontifax IV GP L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner | 2021-05-21 16:05:21 | 7,460,818 0 | 7,460,818 | Form 13D |
| Partlet Holdings Ltd 10% Owner | 2009-11-20 16:14:58 | 4,166,667 0 | 4,166,667 | Form 3 |
| Shabtai Gilad 10% Owner | 2018-05-01 16:39:38 | 3,351,770 0 | 3,351,770 | Form 4 |
| Opko Health Inc. 10% Owner | 2019-05-09 17:15:56 | 1,290,155 0 | 1,290,155 | Form 13D |
| SENECA CAPITAL ADVISORS LLC 10% Owner | 2005-02-14 16:59:41 | 1,273,611 0 | 1,273,611 | Form 13G |
| Pontifax Management 4 G.P. (2015) Ltd. Pontifax (China) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (Israel) IV L.P. Pontifax IV GP L.P. 10% Owner | 2021-05-17 07:03:28 | 0 616,592 | 616,592 | Form 4 |
| FROST PHILLIP MD See Remarks | 2017-12-27 13:43:37 | 593,944 0 | 593,944 | Form 13D |
| FROST PHILLIP MD Frost Gamma Investments Trust Director 10% Owner | 2017-12-27 13:43:37 | 593,944 0 | 593,944 | Form 13D |
| MARTELL RON Chief Executive Officer | 2014-11-20 14:07:13 | 456,364 0 | 456,364 | Form 4 |
| Heft Robert Director | 2017-12-29 18:17:21 | 340,415 0 | 340,415 | Form 3 |
| Ward Robert FORMER CHAIRMAN AND CEO | 2020-03-03 18:30:16 | 244,267 0 | 244,267 | Form 4 |
| Aggarwal Sumit Director | 2025-01-28 17:37:18 | 229,930 0 | 229,930 | Form 4 |
| Williams Gregory C. CHIEF EXECUTIVE OFFICER | 2021-02-26 19:05:19 | 194,629 0 | 194,629 | Form 4 |
| FEDYSZYN SASCHA P VP - Corporate Dev. | 2009-11-23 11:48:54 | 153,460 0 | 153,460 | Form 4 |
| RIOS MIGUEL DE LOS VP - Research | 2014-11-20 09:32:59 | 147,102 0 | 147,102 | Form 4 |
| Huertas Pedro Chief Medical Officer | 2018-05-18 08:05:07 | 137,725 0 | 137,725 | Form 4 |
| FORBES CHRISTOPHER Director | 2014-11-20 17:03:06 | 131,676 0 | 131,676 | Form 4 |
| GALTON BRUCE C Former President & CEO | 2009-12-02 13:26:24 | 98,450 0 | 98,450 | Form 4 |
| Browne Leslie J President | 2014-11-20 09:35:31 | 82,065 0 | 82,065 | Form 4 |
| THOMPSON JOHN PHD Scientific Founder | 2014-11-20 17:02:21 | 53,391 0 | 53,391 | Form 4 |
| STALDER RUEDI Director | 2014-05-20 13:27:32 | 52,405 0 | 52,405 | Form 4 |
| Geffken Daniel E. INTERIM CFO | 2021-12-01 11:06:56 | 50,000 0 | 50,000 | Form 4 |
| Dondero Richard S VP - Preclinical Research | 2014-11-20 09:33:31 | 49,476 0 | 49,476 | Form 4 |
| BROOKS JOEL Chief Financial Officer | 2014-11-20 09:31:43 | 47,300 0 | 47,300 | Form 4 |
| Van Hulst Jack Director | 2014-05-20 13:28:00 | 43,056 0 | 43,056 | Form 4 |
| Rakers Gary D. Controller, PFO/PAO, Treasurer | 2021-03-26 20:50:16 | 42,225 0 | 42,225 | Form 3 |
| SMIDER VAUGHN Chief Scientific Officer 10% Owner | 2014-11-20 16:59:37 | 42,210 0 | 42,210 | Form 4 |
| Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC | 2021-07-30 20:32:44 | 42,074 0 | 42,074 | Form 4 |
| Waksal Harlan Director | 2015-11-23 20:09:51 | 40,000 0 | 40,000 | Form 4 |
| MODUR VIJAY HEAD OF R&D | 2023-01-27 16:02:53 | 30,000 0 | 30,000 | Form 4 |
| GRAZIANO JAMES JOSEPH Chief Technology Officer | 2014-11-20 09:32:22 | 28,140 0 | 28,140 | Form 4 |
| RECTOR DAVID See Remarks | 2017-12-21 20:19:18 | 27,500 0 | 27,500 | Form 4 |
| Snow David P. FORMER CHIEF BUSINESS OFFICER | 2020-03-04 14:30:24 | 22,955 0 | 22,955 | Form 4/A |
| Walts Alan Edmund Director | 2025-01-28 17:34:29 | 20,442 0 | 20,442 | Form 4 |
| Noiman Silvia Director | 2020-05-22 16:10:24 | 20,000 0 | 20,000 | Form 4 |
| Kleijwegt Martijn Director | 2020-05-22 16:10:15 | 20,000 0 | 20,000 | Form 4 |
| Avnur Zafrira Director | 2022-06-17 08:23:51 | 20,000 0 | 20,000 | Form 4 |
| Nussbaum Ran Director | 2022-06-17 08:26:16 | 20,000 0 | 20,000 | Form 4 |
| PAREKH RAJESH B Director | 2022-06-17 08:27:06 | 20,000 0 | 20,000 | Form 4 |
| Seehra Jasbir Director | 2022-06-17 08:28:16 | 20,000 0 | 20,000 | Form 4 |
| Veinrib Gadi Director | 2022-06-17 08:28:59 | 20,000 0 | 20,000 | Form 4 |
| Rubin Steven D Director | 2025-01-28 17:36:23 | 19,500 0 | 19,500 | Form 4 |
| Androski Lindsay Director | 2025-01-28 17:35:27 | 19,500 0 | 19,500 | Form 4 |
| MacDonald Stephen G. VP FINANCE & ACCTG, TREASURER | 2021-02-17 18:43:27 | 18,849 0 | 18,849 | Form 4 |
| BRACA JOHN N See Remarks | 2017-12-21 20:18:35 | 18,190 0 | 18,190 | Form 4 |
| QUICK THOMAS C Director | 2014-05-20 13:28:32 | 13,149 0 | 13,149 | Form 4 |
| WEAVER GREGORY L FORMER CHIEF FINANCIAL OFFICER | 2020-03-16 16:10:15 | 10,431 0 | 10,431 | Form 4 |
| Isabelle Warren John Director | 2014-05-20 13:28:56 | 6,038 0 | 6,038 | Form 4 |
| Kariv Tomer Director | 2023-01-31 16:08:40 | 2,859 0 | 2,859 | Form 4 |